CD4 and neoplasm: There was a pronounced reduction in the percentage and absolute number of OT-II CD4+FoxP3.gfp+ T cells harvested from the spleen, tumor-draining lymph nodes, and tumor of mice treated with SA-4-1BBL as compared with untreated controls (Fig. 4A–D).